A drug administered to a patient for treatment, listed in SEER*Rx as a chemotherapeutic, hormonal or immunotherapy agent should be coded under chemotherapy [#1390], hormone therapy [#1400] or immunotherapy [#1410] regardless of the primary site(s) listed in SEER*Rx for that agent. Do not code under the data item, Other Therapy [NAACCR #1420]. Refer to the 2026 SEER manual for more information.

Name Category Primary Site Code?
tgDCC-E1A Biologic therapy (BRM, immunotherapy) Head & neck, ovarian cancer Yes
sibrotuzumab Chemotherapy Breast, colorectal, lung, other cancer, pancreatic Yes
sT4 AIDS drug No
rgp120/HIV-1 (IIIB) AIDS drug No
rgp120 CHO AIDS drug No
recMAGE-A3+AS15 Biologic therapy (BRM, immunotherapy) Melanoma, NSCLC Yes
radiotherapy Radiation Yes
rV-MART-1 Biologic therapy (BRM, immunotherapy) Skin cancer Yes
rV-GP100 Biologic therapy (BRM, immunotherapy) Skin cancer Yes
rF-gp100 Biologic therapy (BRM, immunotherapy) Skin cancer Yes
rF-Tyrosine Vaccine Biologic therapy (BRM, immunotherapy) Skin cancer Yes
rF-Mgp100 Biologic therapy (BRM, immunotherapy) Skin cancer Yes
rF-MART-1 Biologic therapy (BRM, immunotherapy) Skin cancer Yes
rCD4 AIDS drug No
pivaloyloxymethylbutyrate Chemotherapy Liver, lung cancer Yes
p53 Tumor Suppressor Gene Biologic therapy (BRM, immunotherapy) Head & neck, liver, ovarian cancer Yes
hypoxia-inducible factor-2 alpha (HIF-2α) inhibitor MK-6482 Chemotherapy Kidney Yes
hR3 Biologic therapy (BRM, immunotherapy) Head & neck cancer Yes
hIL13-PE38QQR (ligand targeted toxin) Chemotherapy Kidney cancer Yes
gp100 Plasmid Vector in Gold Particles Biologic therapy (BRM, immunotherapy) Skin cancer Yes
gp100 Peptide Vaccine Biologic therapy (BRM, immunotherapy) Skin cancer Yes
gp100 DNA Vaccine Biologic therapy (BRM, immunotherapy) Skin cancer Yes
diazooxonorleucine Chemotherapy Skin cancer Yes
dabrafenib Chemotherapy Melanoma, Lung, Thyroid Yes
cAC10-vcMMAE(4) Chemotherapy Hodgkin lymphoma Yes
Glossary